05/17/2024
4:36 PM | CytomX Therapeutics (Issuer)
Su Zhen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
4:36 PM | CytomX Therapeutics (Issuer)
Young Matthew P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
4:31 PM | Ashworth Alan (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
4:32 PM | CytomX Therapeutics (Issuer)
Gilbert Halley E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
4:33 PM | CytomX Therapeutics (Issuer)
Jones Elaine V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
4:34 PM | CytomX Therapeutics (Issuer)
Meyers James R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
4:34 PM | CytomX Therapeutics (Issuer)
Mohindru Mani (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
05/13/2024
3:00 PM | Cormorant Asset Management, LP (Filed by)
CytomX Therapeutics (Subject)
| Form SC 13G | |
05/08/2024
3:41 PM | CytomX Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2024
5:06 AM | CytomX Therapeutics (Filer)
| Form DEFA14A | |
04/04/2024
3:31 PM | CytomX Therapeutics (Filer)
| Form DEF 14A | |
04/04/2024
3:33 PM | CytomX Therapeutics (Filer)
| Form DEFA14A | |
03/28/2024
6:12 PM | CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
4:15 PM | CytomX Therapeutics (Filer)
| Form PRE 14A | |
03/22/2024
3:27 PM | CytomX Therapeutics (Issuer)
Su Zhen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:36 PM | CytomX Therapeutics (Issuer)
Landau Jeffrey B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:37 PM | BELVIN MARCIA (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:38 PM | CytomX Therapeutics (Issuer)
Ogden Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:40 PM | CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:41 PM | CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
3:30 PM | CytomX Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/19/2024
7:41 PM | CytomX Therapeutics (Issuer)
Ogden Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
7:43 PM | CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
7:44 PM | CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
7:37 PM | Chu Yu-Waye (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
7:38 PM | BELVIN MARCIA (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
7:40 PM | CytomX Therapeutics (Issuer)
Landau Jeffrey B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
6:54 PM | BELVIN MARCIA (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
6:55 PM | CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
6:56 PM | CytomX Therapeutics (Issuer)
Landau Jeffrey B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
6:57 PM | CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
6:58 PM | CytomX Therapeutics (Issuer)
Ogden Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/22/2023
6:12 PM | CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/22/2023
6:13 PM | CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/22/2023
6:15 PM | CytomX Therapeutics (Issuer)
Landau Jeffrey B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/22/2023
6:16 PM | BELVIN MARCIA (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2023
11:15 PM | CytomX Therapeutics (Filer)
| Form EFFECT | |
08/24/2023
3:05 PM | CytomX Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2023
8:40 PM | CytomX Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
07/20/2023
4:17 PM | Chu Yu-Waye (Reporting)
CytomX Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/20/2023
4:18 PM | Chu Yu-Waye (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
SHOCKING Crypto Leak… (Ad) A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products.
If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE…
The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
 Claim your free seat by clicking here now. |
06/20/2023
3:06 PM | CytomX Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2023
4:49 PM | CytomX Therapeutics (Issuer)
Jones Elaine V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:49 PM | CytomX Therapeutics (Issuer)
Gilbert Halley E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:50 PM | Ashworth Alan (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:51 PM | CytomX Therapeutics (Issuer)
Young Matthew P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:52 PM | CytomX Therapeutics (Issuer)
Mohindru Mani (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:54 PM | CytomX Therapeutics (Issuer)
Meyers James R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
